Singapore, April 9 -- China-based ATLATL Innovation Center, a global innovation platform for life science research and development, has announced an agreement with Japan's Daiichi Sankyo to leverage ATLATL's multi-regional innovative R&D network and expertise in the Asia-Pacific (APAC) biotech sector to help Daiichi Sankyo identify high-quality R&D platform technologies and accelerate the transformation and implementation of innovative science in order to potentially bring new treatment options to patients worldwide.

As a builder of life science innovation ecosystems, ATLATL has developed a one-stop global innovation platform based on its engineered life science "Super Server" model, integrating R&D infrastructure, technical se...